Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancers

June 27, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search